| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JC.2011-2735 |
| P698 | PubMed publication ID | 22278420 |
| P2093 | author name string | Paolo Vitti | |
| Emilio Fiore | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | papillary thyroid cancer | Q2292945 |
| P304 | page(s) | 1134-1145 | |
| P577 | publication date | 2012-01-25 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease | |
| P478 | volume | 97 |
| Q37582449 | 2013 ETA Guideline: Management of Subclinical Hypothyroidism |
| Q90873117 | A Rare Case of Thyrotropin-Secreting Pituitary Adenoma Coexisting with Papillary Thyroid Carcinoma Presenting with Visual Disturbance without Hyperthyroidism |
| Q37725502 | A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors |
| Q38934885 | Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update |
| Q48157390 | Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer |
| Q35931160 | Association between rs12045440 Polymorphism in the CAPZB Intron and Serum TSH Concentrations in Chinese Thyroid Tumor Patients |
| Q86743287 | Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma |
| Q34602449 | Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis |
| Q49606886 | Attributable risk fraction of four lifestyle risk factors of thyroid cancer: a meta-analysis |
| Q34895975 | Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control study |
| Q94592752 | Clinicopathologic Differences Between Micropapillary and Papillary Thyroid Carcinoma |
| Q45780286 | Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer |
| Q37733487 | Coexistence of thyroid-stimulating hormone-secreting pituitary adenoma and graves' hyperthyroidism. |
| Q99583222 | Correlation between thyroid autoantibodies and the risk of thyroid papillary carcinoma |
| Q51107309 | Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? |
| Q38442353 | Evaluation of serum thyroid-stimulating hormone as indicator for fine-needle aspiration in patients with thyroid nodules. |
| Q37710243 | Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects. |
| Q43842904 | Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. |
| Q36265557 | High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma. |
| Q46929617 | Higher TSH level is a risk factor for differentiated thyroid cancer |
| Q96231220 | Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer |
| Q48027250 | Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study |
| Q55427690 | Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves' disease: a systematic review and meta-analysis of cohort studies. |
| Q40479779 | Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis. |
| Q85290845 | Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer |
| Q35507643 | Iodine, thyroid autoimmunity and cancer |
| Q53634080 | Large thyroid cyst in a patient with congenital hypothyroidism. |
| Q26765262 | Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits |
| Q52639247 | Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis. |
| Q38766990 | Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β. |
| Q50861094 | Myo-inositol and melatonin in the menopausal transition. |
| Q33915384 | New insights in risk stratification of differentiated thyroid cancer. |
| Q35044063 | Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies |
| Q53532399 | Oral liquid levothyroxine solves the problem of tablet levothyroxine malabsorption due to concomitant intake of multiple drugs. |
| Q33648683 | P21-activated kinase 4 involves TSH induced papillary thyroid cancer cell proliferation |
| Q58792086 | Plasma ω-3 and ω-6 fatty acids in thyroid diseases |
| Q37010834 | Predicting malignancy in thyroid nodules: feasibility of a predictive model integrating clinical, biochemical, and ultrasound characteristics. |
| Q42709095 | Pretreatment BMI Is Associated with Aggressive Clinicopathological Features of Papillary Thyroid Carcinoma: A Multicenter Study. |
| Q37460181 | Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis |
| Q37376426 | Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer |
| Q38914370 | Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer |
| Q36439404 | Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor |
| Q37559124 | Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease |
| Q33609019 | Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma |
| Q52664598 | TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer. |
| Q50317254 | Targeted Next-Generation Sequencing Analysis of a Pendred Syndrome-Associated Thyroid Carcinoma |
| Q92358562 | The Difference in Thyroid Stimulating Hormone Levels between Differentiated Carcinoma and Benign Enlargement |
| Q57838206 | The Role of Polybrominated Diphenyl Ethers in Thyroid Carcinogenesis: Is It a Weak Hypothesis or a Hidden Reality? From Facts to New Perspectives |
| Q54999825 | The Role of Targeted Therapies or Nonsurgical Treatment of Thyroid Malignancies: Is Surgery Being Replaced? |
| Q38217579 | The administration of L-thyroxine as soft gel capsule or liquid solution |
| Q92301978 | The influence of thyroid nodule size on the diagnostic efficacy and accuracy of ultrasound guided fine-needle aspiration cytology |
| Q96229811 | The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC) |
| Q36969850 | Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer |
| Q55405887 | Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy. |
| Q64118488 | Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan |
| Q38716038 | Thyroid nodules and thyroid autoimmunity in the context of environmental pollution. |
| Q55518505 | Thyroid nodules in centenarians: prevalence and relationship to lifestyle characteristics and dietary habits. |
| Q26997448 | Thyroid nodules in pediatrics: which ones can be left alone, which ones must be investigated, when and how |
| Q37630088 | Thyrotropin signaling confers more aggressive features with higher genomic instability on BRAF(V600E)-induced thyroid tumors in a mouse model |
| Q38705219 | Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management |
Search more.